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Abstract 
The interventricular septum (IVS) separates the right and left ventricles of the heart, 
preventing ​the mixing of blood from the oxygenated systemic circulation with that of the 
deoxygenated pulmonary circulation.​ Prior research has established the role of cardiac 
transcription factors in the formation of the IVS. However, the principal molecular mechanism 
that governs IVS formation remains unknown. To understand the key events that occur during 
septation we performed a detailed morphological characterization of septation at critical 
developmental time points. In addition, we used genetic lineage tracing studies to identify the 
developmental origins of cardiac cells that populate the septum. Finally, as an initial means to 
assess the role that proliferation has in the maturation of the interventricular septum we 
performed proliferation analysis of cells within the septum. Analysis of the genetic lineage 
tracing studies confirm that the interventricular septum is mostly derived from second heart field 
cells. The proliferation analysis revealed an appreciable number of proliferating cells in the IVS. 
However, there does not appear to be a distinct regional distribution of proliferating cells within 
the septum. These works provide a detailed characterization of morphological and genetic events 
that contribute to septum development that will be used as a fundamental basis from which to 
further study the molecular mechanisms that dictate septum formation.  
 
Introduction  
The heart is the first organ to begin development in the human embryo. ​Heart 
organogenesis begins with the differentiation of the lateral plate mesoderm, which comprises 
first heart field (FHF) cells ​(Miquerol & Kelly, 2013)​. The term heart field refers to a spatial area 
 
of cells with distinct gene expression that are destined to give rise to specific structures 
(Abu-Issa & Kirby, 2007)​ ​(Harvey, 2002)​. The lateral plate mesoderm undergoes morphogenesis 
to form the linear heart tube ​(Harvey, 2002)​. The addition of the second heart field (SHF) cells, 
originating from the splanchnic mesoderm, at the heart tube poles will give rise to the right 
ventricle, outflow tract myocardium and smooth muscle at the base of the great arteries ​(Harvey, 
2002)​. Previous studies have shown that the IVS is derived entirely from the SHF ​(Black, 2007)​. 
Although, a clear consensus has not been reached. The developing heart then undergoes chamber 
formation, after which septation of the heart occurs ​(Miquerol & Kelly, 2013)​. Septation 
describes the general process by which the right ventricle and left ventricle are separated by the 
formation of the IVS. ​Septation begins 7.5 weeks after gestation and is completed by 9 weeks in 
humans ​(Krishnan et al., 2014)​. In contrast, the IVS begins to form at e10.5, e denotes embryonic 
days, and is completed at e14.5 in mice ​(Krishnan et al., 2014)​. 
Despite temporal differences, heart development proceeds in the same sequential manner 
in mice as in humans, making it a valuable model organism for heart development ​(Krishnan et 
al., 2014)​. Past studies in mice have established the roles that cardiac transcription factors play in 
IVS development. Deletion or knockout studies have implicated Tbx5 ​(Horb & Thomsen, 1999) 
(Takeuchi, 2003)​, Hand1/2​ ​(McFadden et al., 2005)​ and SRF ​(Parlakian et al., 2004)​, among 
others, by observing defects in the IVS when their expression is altered. Although these 
transcription factors are known to contribute to IVS development, they also play other roles in 
heart development. The misexpression of Tbx5 results in the loss of the IVS but also specifies 
the identity of the left ventricle ​(Takeuchi, 2003)​. This makes it difficult to understand wherever 
the observed contributions to septum development are direct or secondary interactions.  
 
The transcription factors implicated in IVS defects in mice have been found to be 
misexpressed in humans with interventricular septum defects ​(McCulley & Black, 2012)​. When 
the IVS does not form completely, this results in gaps which permit the mixing of oxygenated 
and deoxygenated blood ​(CDC, 2019)​. Low-oxygen blood is not sufficient to support bodily 
functions, resulting in the heart working harder to maintain optimal oxygen levels ​(CDC, 2019)​. 
IVS defects comprise the largest portion of congenital heart defects (CHD), which is the most 
common form of birth defects ​(Linde et al., 2011)​.​ This represents 2.62 incidences of IVS 
defects per 1,000 live births ​(Linde et al., 2011)​.​ Despite the prevalence and ramifications of IVS 
defects, the principal molecular mechanism by which the septum forms remains unknown 
(Franco et al., 2006)​. 
Many theories have been proposed to explain the development of the IVS. The proposed 
principal molecular mechanisms include asymmetrical proliferation, chemotaxis and mechanical 
stress. Increased proliferation of cardiomyocytes at the apical end of the IVS is proposed to drive 
the growth superiorly from the apex ​(Harh & Paul, 1975)​. It has also been theorized that 
chemotaxis drives growth ​(Conlon, Frank, Unpublished.)​. This theory speculates that there is an 
elusive chemical stimulus which signals to the cardiomyocytes of the developing IVS to crawl 
towards the stimulus ​(Conlon, Frank, Unpublished.)​. Lastly, researchers have suggested that as 
the developing heart undergoes chamber formation, this creates mechanical stress between the 
right and left ventricle ​(Van Mierop & Kutsche, 1986)​. This tension drives the cells at the base of 
the heart superiorly, creating the IVS ​(Van Mierop & Kutsche, 1986)​. Previous research has not 
been able to produce concrete evidence that the respective theories are the principal molecular 
mechanism that drive IVS growth.  
 
Numerous studies have investigated IVS development in mutant mice, however, as 
previously stated confounding variables make it difficult to state direct relationships. The gap of 
fundamental information regarding normal IVS development has motivated this study. A 
histological analysis of the IVS was conducted with hematoxylin and eosin (H&E). In our study 
we developed an atlas of normal IVS formation in wildtype embryos to provide a visual 
representation of morphological progression. Lineage tracing studies identify the developmental 
origins of the IVS cells, focusing future research on the cell population that constitutes the IVS. 
The Cre-lox system was used to lineage trace the FHF and SHF using Mef2c and HCN4, known 
lineage markers for the respective cells. Lastly, a proliferation analysis was conducted to identify 
the patterning of proliferative cells within the septum to help determine if directional growth 
could contribute to septum formation. ​Our data establishes that the vast majority of cells that 
comprise the interventricular septum are mostly derived from second heart field cells, and there 
does not appear to be a regional distribution of proliferating cells within the septum. 
 
Materials and Methods 
Animals  
Wild-type, Mef2C​Cre/+​; R26R​tom/tom​ and HCN4​Cre/+​; R26R​tom/tom ​mice were used in this experiment 
following established ethical protocols by ​the Institutional Animal Care and Use Committee at 
the University of North Carolina and conforms to the Guide for the Care and Use of Laboratory 
Animals.​ The Mef2C​Cre/+​; R26R​tom/tom​ mice were obtained by crossing male Mef2c​Cre/+​ ; 
R26R​tom/tom​ and female R26R​tom/ tom​ mice. The HCN4​Cre/+​; R26R​tom/tom​ mice were obtained by 
crossing male HCN4​Cre/+​ ; R26R​tom/tom​ and female R26R​tom/ tom​ mice. The HCN4​Cre/+​; R26R​tom/tom 
 
pregnant female mice were treated with 0.75 μg/g of tamoxifen in corn oil  via oral gavage on 
embryonic day 7.5.  
Collection of the Embryos  
The embryos were collected in the morning at the desired developmental time point. The 
pregnant mice were euthanized in a CO​2​ chamber and cervical dislocation was used as a 
secondary means of euthanization. The embryos and dissected hearts were placed in cold PBS. 
The tails of transgenic embryos were clipped to be used for genotyping. The genotypes were 
determined by PCR using primers for Cre recombinase and R26R​tom​. The embryos were then 
fixed in 4% PFA and stored overnight at​ ​4℃.  
 Forward Primer Reverse Primer 
Cre GTC CCC TTC TCC ATC TCC AG GCA AAC GGA CAG AAG CAT TT 
R26R Tomato Wild 
Type 
AAG GGA GCT GCA GTG GAG TA CCG AAA ATC TGT GGG AAG TC 
R26R Tomato Mutant 
Type 
CTC TTC CTG TAC GGC ATG G GGC ATT AAA GCA GCG TAT CC 
 
Paraffin Embedding and Sectioning 
Fixed embryos were washed with 1x PBS. The embryos were dehydrated in 25% ethanol for 15 
minutes, repeating twice. This was repeated with increasing increments of 25% ethanol. The 
embryos were stored overnight in 100% ethanol at 4℃. The embryos were dehydrated by 
processing in a series of 100% ethanol, 50% ethanol/ 50% xylene, 100% xylene for 10 minutes 
each, repeating each step twice. At 58℃ the embryos were processed with 50% xylene/ 50% 
paraffin for 30 minutes and lastly 100% paraffin for 30 minutes each, repeating three times. The 
embryos were then embedded in paraffin. The embedded embryos were sectioned using a 
 
microtone to obtain 10 μm thick cross-sectional sections and mounted on slides. The slides were 
stored at room temperature.  
Morphological Analysis  
For the morphological analysis, paraffin embedded slides were deparaffinized, rehydrated, and 
were stained with hematoxylin and eosin using standard methods. Slides were then destained and 
dehydrated before mounting.  
Paraffin Embedded Tissue Fluorescence Immunohistochemistry  
 The slides were processed through a series of xylene, 100% ethanol, 95% ethanol, and 1x PBS.  
The slides were steamed with sodium citrate for 20 minutes and then allowed to rest. The slides 
were washed with 1x PBS before being blocked with 10% goat serum in 1x PBS TritonX-100 for 
an hour in a humidity chamber. The slides were incubated overnight with tropomyosin primary 
antibody (DSHB) 1:50 and Phospho-Histone H3 primary antibody (Miliipore) 1:400 dilution. 
The slides were incubated with the secondary antibody, Alexa 488 (Invitrogen) 1:1000 dilution 
and Alexa 546 (Invitrogen) 1:1000 dilution, for one hour at room temperature. The antibodies 
were diluted in 1xPBS with 1% goat serum and 0.1% TritonX-100. Slides were counterstained 
with DAPI (200ng/ml of DAPI in 1xPBS) and mounted with Mountant PermaFluor (Thermo 
Scientific).  
OCT Embedding and Sectioning 
Fixed embryos were washed with 1x PBS at room temperature and were stored in 15% sucrose 
solution overnight. The following day they were transferred to a 30% sucrose solution overnight. 
The embryos were placed in Optimal Cutting Temperature (OCT) to remove residual sucrose 
 
before embedding in OCT. A cryostat (-20˚C) was used to obtain 10 μm thick sections. The 
sections were stored at -80°C.  
Frozen Fluorescence Immunohistochemistry of the First and Second Heart Field  
The OCT embedded slides were thawed at room temperature. The slides were washed with 1x 
PBS before being blocked with 10% goat serum in 1x PBS TritonX-100 for an hour in a 
humidity chamber. Slides were incubated with tropomyosin primary antibody (DSHB) 1:50 
dilution overnight. The slides were incubated with the secondary antibody, Alexa 488 
(Invitrogen) 1:1000 dilution, for one hour at room temperature. The primary and secondary 
antibodies were diluted in 1xPBS with 1% goat serum and 0.1% TritonX-100. Slides were 
counterstained with DAPI (200ng/ml of DAPI in 1xPBS) and mounted with Mountant 
PermaFluor (Thermo Scientific).  
 
Results  
Morphological Analysis of Wild Type Embryo  
To understand the key events that occur during septation we performed a morphological 
characterization of septation at e10.5 to e14.5. The wild-type (CD1) embryonic hearts in the 
sagittal plane were stained with H & E. ​The IVS can be identified by the dense tissue, whereas 
the ventricles are hollow in the center. The sections with IVS are represented with an asterisk 
(Fig. 2). The earliest the IVS can be identified is in e10.5 (Fig. 2, A5). At this point in 
development the IVS has not completely partitioned the right and left ventricles (Fig. 2, A5). The 
interventricular foramen can be observed superior to the apex of the septum (Fig 2. D4). 
Development occurs rapidly in mice that by e11.5, the heart has undergone appreciable growth 
 
(Fig. 2 B1-5). At e11.5 the section B4 appears to be structurally similar to B5 in terms of septum 
length and width. The only perceivable difference between the sections is that B4 has gaps 
throughout the septum whereas in B5 the tissue is uninterrupted. This pattern can also be 
observed at e12.5 in sections C3 and C4. In C4 the IVS is continuous tissue but the 
interventricular foramen persists. At e13.5, septation is still incomplete (Fig. 2, D4-5). The size 
of the interventricular foramen between the time points e12.5 and e13.5 are indistinguishable 
(Fig. 2, C4, D5). However, the IVS in D5 has increased in width and length. Development of the 
IVS proceeds until e14.5 (Fig. 2, E). In E3 the IVS is fully formed, the interventricular foramen 
has disappeared. Overall, as the IVS progresses from e10.5 to e14.5 the interventricular foramen 
becomes smaller (Fig. 2). Despite the persistence of the interventricular foramen from e10.5 to 
e13.5, the tissue of the IVS lacks any gaps in each time point. The tissue density appears 
consistent in each IVS section (Fig. 2, A5, B5, C4, D5, E3). The morphological analysis 
establishes that IVS development begins at e10.5 and ends at e14.5. Overall, as development 
progresses the interventricular foramen becomes smaller, but the tissue density in the developing 
IVS remains consistent.  
 
Figure 1. Schematic illustration of heart adapted from 
Ward et al., 2011​. A) Sagittal section illustrating the 
plane used for the histological analysis. B) Transverse 
section illustrating the plane used for the lineage 
tracing studies and proliferation analysis. C) Frontal 









Figure 2. Histological analysis of wild-type embryos at time points e10.5 to e14.5. The time points are in order of                    
increasing age. Within each time point the sections proceed from the right to the left of the heart. The upper images                     
represent the rightmost sections of the heart. The cytoplasm is stained pink while the nuclei are stained purple.                  
Asterisks indicate images that contain interventricular septum, characterized by the thickening of the tissue. AR,               
aortic root; PR, pulmonary root; IF, interventricular foramen. 
 
The Majority of Cells in the Interventricular Septum are Second Heart Field Derived 
To determine the role of the second heart field in the developmental  origins of the IVS 
cells, a lineage tracing analysis was conducted. T​ransgenic mice for the SHF fate marker, Mef2c, 
 
were created using the Cre-loxP system (Fig. 3A). The Cre gene is downstream from the Mef2c 
activator (Fig. 3A). The Cre protein excises loxP sites to express the td tomato reporter, marking 
the cells that are derived from Mef2cr expressing progenitors (Fig. 3A). Tropomyosin marks the 
cardiomyocytes and DAPI marks the nuclei (Fig. 3B).​ ​The cells with SHF developmental origins 
are confined to the right ventricle and IVS (Fig. 3B). However, there does appear to be minimal 
staining of the left ventricle in each time point (Fig. 3B). At e10.5 the entire IVS is marked for 
the SHF fate maker (Fig. 3B, A-C). This observation is also seen in e11.5 and e12.5 (Fig. 3B 
D-I). The lineage tracing analysis of the SHF confirms that the right ventricle and IVS are 








Figure 3. Lineage tracing study of Mef2C​Cre/+​; R26R​tom/tom embryos adapted from ​Poltorak & Schraml, 2015 and                
Davies​, Unpublished. A) Schematic of the crosses made to obtain the Mef2C​Cre/+​; R26R​tom/tom embryos. Male               
Mef2c​Cre/+ ; R26R​tomato/tomato and female R26R​tomato/ tomato mice were crossed. B) Transverse sections of Mef2C​Cre/+​;               
R26R​tom/tom embryos from time points e10.5 to e12.5. Within a time point, the rows progress from anterior to                  
posterior. The columns within a time point contain the same image with different cardiac markers overlayed. Red,                 
SHF; Green, tropomyosin; Blue, nuclei; RV, right ventricle; LV, left ventricle; IVS, interventricular septum.  
 
The First Heart Field Does Not Contribute to the Interventricular Septum  
In parallel, a lineage tracing analysis for the first heart field marker, HCN4, was 
conducted to assess its contribution to the septum. Using the Cre-loxP system, HCN4​Cre/+​; 
R26R​tom/+​ embryos were created ranging from e10.5 to e11.5. Endogenous td tom marks the 
cardiomyocytes derived from HCN4 expressing progenitors (Fig. 4). Tropomyosin marks the 
cardiomyocytes and DAPI marks the nuclei (Fig. 4). The cardiomyocytes residing in the left 
 
ventricle were the only cells marked for HCN4 (Fig. 4). The lineage tracing analysis of the FHF 
confirms that only the left ventricular cardiomyocytes are positive for the FHF marker, HCN4. 
Figure 4. Lineage tracing study of HCN4​Cre/+​; R26R​tom/tom embryos. Transverse sections of HCN4​Cre/+​; R26R​tom/tom              
embryos from time points e10.5 to e11.5. Within a time point, the rows progress from anterior to posterior. The                   
columns within a time point contain the same image with different cardiac markers overlayed. Red, SHF; Green,                 
tropomyosin; Blue, nuclei; RV, right ventricle; LV, left ventricle; IVS, interventricular septum.  
 
Proliferation is Symmetrical Throughout the Interventricular Septum  
To determine the localization of proliferation in the IVS throughout development, a 
proliferation analysis using the mitotic division marker, phosphohistone H3 (PHH3), was 
conducted. Tropomyosin  marks the cardiomyocytes and DAPI marks the nuclei (Fig. 4). 
 
Wild-type embryos ranging from e10.5 to e12.5 were used for this study. At e10.5 proliferation 
was minimal and dispersed evenly in the IVS (Fig. 5, A’-C’). At e11.5, proliferation remained 
distributed equally throughout the septum (Fig. 5 D’-F’). The peak in PHH3 positive cardiac 
cells occurred at e12.5 and remained equally distributed (Fig. 5, G’-I’). The proliferation analysis 
establishes that proliferation remains equally distributed as development proceeds. 
Figure 5. Proliferation analysis of the IVS in wild-type embryos. Transverse sections of embryos from time points                 
e10.5 to e12.5. Within each time point, the progression of IVS proceeds from the anterior to the posterior. Parallel to                    
each image, the IVS has been magnified for clarity. Red, PHH3; Green, tropomyosin; Blue, nuclei; RV, right                 
ventricle; LV, left ventricle; IVS, interventricular septum.  
 
Discussion 
In this study we created a detailed map of morphological changes in normal IVS 
development. Our morphological analysis supports prior research that the IVS development 
 
begins at e10.5 and ends at e14.5 ​(Krishnan et al., 2014)​. From this study, we can draw 
conclusions on the directionality of the movement of IVS cardiomyocytes as development 
proceeds. As development proceeds from e10.5 to e14.5, the interventricular foramen becomes 
smaller until disappearing at e14.5 (Fig. 2). This indicates that the IVS grows superiorly from the 
floor of the common ventricle. Despite the incomplete closure of the interventricular foramen, 
the density of the IVS remains consistent throughout development (Fig. 2). This suggests that the 
cardiomyocytes fill the IVS tissue before closing the interventricular foramen.  
The analysis of two fate markers, which are expressed in the progenitor cells of the FHF 
or SHF, reveal complementary labeling of the IVS cardiomyocytes. The lineage tracing analysis 
of the SHF indicates that a significant portion of the IVS cardiac cells are derived from a Mef2c 
expressing progenitor (Fig. 3B). The FHF lineage tracing study confirmed that the IVS was 
negative for cells derived from the FHF (Fig. 4). Combining the lineage tracing studies, it can be 
established that the IVS cardiomyocytes are primarily derived from second heart field cells. This 
is supported by the current literature regarding the developmental origins of the IVS 
cardiomyocytes ​(Black, 2007)​. The SHF lineage tracing analysis showed that the right ventricle 
cardiomyocytes were positive for Mef2c (Fig. 3B). It has been established that the right ventricle 
is SHF derived ​(Harvey, 2002)​. This indicates that the Cre-loxP system was able to accurately 
trace the cells whose progenitors turn on the SHF fate marker, Mef2c. However, there does 
appear to be minimal staining of the left ventricle in each time point (Fig. 3B). Similarly, it has 
been established that the left ventricle is FHF derived. In the FHF lineage tracing analysis, only 
the left ventricle cells were positive for the FHF marker, verifying the accuracy of the Cre-loxP 
system (Fig. 4).  
 
It has been proposed that asymmetrical proliferation, with increased proliferation at the 
apical end of the septum, could account for the growth of the IVS. In this study we used 
immunohistological analysis of the mitotic marker phosphohistone H3 during critical time points 
of heart development, as an initial means of determining the role that proliferation plays in 
septation. Our study determined that proliferation was evenly distributed throughout the septum 
at e10.5 to e12.5 (Fig. 5). Preliminary, our data suggests that the theory of asymmetrical 
proliferation is not the principal molecular mechanism that drives IVS growth. If this had been 
the case, there should have been a greater number of cardiomyocytes positive for undergoing 
mitosis at the apical end compared to the rest of the IVS. However, a more comprehensive 
analysis must be conducted to fully understand the role of proliferation in the development of the 
interventricular septum. One limitation of our current study is that the proliferation analysis was 
only conducted in transverse sections of the developing heart. Therefore, in future studies we 
plan to perform the same proliferation analysis that incorporates multiple anatomical planes to 
ensure we have a complete representation of cardiomyocyte proliferation in the IVS. Although 
asymmetrical proliferation does not appear to be the principal molecular mechanism, 
proliferation could still play an important role in IVS development. The morphological analysis 
suggests that growth of the septum occurs from two directions, superiorly from the common 
ventricle and laterally from the ventricles. Proliferation of IVS cardiomyocytes could account for 
the uniform tissue density throughout septation (Fig. 2).  
Understanding the key steps of normal IVS development can be used as a tool to study 
abnormal development as seen in patients with congenital heart defects. In our current study we 
demonstrated that the interventricular septum is mostly derived from second heart field cells. 
 
These studies advance our knowledge of the developmental potency of the SHF cells. 
Additionally, it highlights the importance of further studying the molecular interactions that 
dictate the cell fate of SHF cells. In the future, experimental manipulations of the molecular 
interactions that dictate the SHF cell fate could be informative of the origins of interventricular 
septum defects. Finally, our preliminary proliferation analysis suggests that regional distribution 
of proliferating cells within the septum is not a primary mechanism of IVS development. In the 
future we also plan to investigate additional molecular mechanisms that contribute to IVS 
formation such as mechanical stress and chemotaxis.  
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